Insider Transactions in Q4 2020 at Inari Medical, Inc. (NARI)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 24
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
39,068
-0.16%
|
$3,203,576
$82.16 P/Share
|
|
Dec 23
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
265,768
-0.72%
|
$21,527,208
$81.84 P/Share
|
|
Dec 22
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
284,022
-0.49%
|
$21,869,694
$77.11 P/Share
|
|
Dec 21
2020
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,500
-5.07%
|
$111,000
$74.0 P/Share
|
|
Dec 21
2020
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+4.82%
|
$0
$0.46 P/Share
|
|
Dec 21
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
194,950
-0.59%
|
$14,036,400
$72.52 P/Share
|
|
Dec 18
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
216,192
-1.05%
|
$15,349,632
$71.4 P/Share
|
|
Dec 18
2020
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
27,400
-2.47%
|
$1,918,000
$70.84 P/Share
|
|
Dec 11
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
71,446
-0.51%
|
$4,715,436
$66.99 P/Share
|
|
Dec 10
2020
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.07%
|
$476,000
$68.01 P/Share
|
|
Dec 10
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
136,043
-0.64%
|
$9,114,881
$67.69 P/Share
|
|
Dec 09
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
155,224
-0.71%
|
$10,244,784
$66.65 P/Share
|
|
Dec 08
2020
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.41%
|
$0
$0.46 P/Share
|
|
Dec 08
2020
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.05%
|
$325,000
$65.11 P/Share
|
|
Dec 08
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
28,677
-0.39%
|
$1,864,005
$65.35 P/Share
|
|
Dec 07
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
70,939
-0.96%
|
$4,611,035
$65.1 P/Share
|
|
Dec 04
2020
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.14%
|
$1,920,000
$64.54 P/Share
|
|
Dec 04
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
14,482
-0.2%
|
$941,330
$65.01 P/Share
|
|
Dec 03
2020
|
Donald B Milder Director |
SELL
Bona fide gift
|
Indirect |
210,000
-4.2%
|
-
|
|
Dec 03
2020
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+46.51%
|
$0
$0.46 P/Share
|
|
Dec 03
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,620
-0.02%
|
$105,300
$65.03 P/Share
|
|
Dec 02
2020
|
Kirk G. Nielsen Director |
SELL
Other acquisition or disposition
|
Indirect |
532,475
-43.72%
|
-
|
|
Dec 02
2020
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Direct |
5,869
+28.52%
|
-
|
|
Dec 02
2020
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Indirect |
108,490
+50.0%
|
-
|
|
Dec 02
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
79,025
-0.26%
|
$5,057,600
$64.81 P/Share
|
|
Dec 01
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
164,688
-0.72%
|
$11,198,784
$68.02 P/Share
|
|
Nov 30
2020
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,500
-2.87%
|
$234,500
$67.74 P/Share
|
|
Nov 30
2020
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+9.97%
|
$0
$0.46 P/Share
|
|
Nov 30
2020
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
27,400
-2.24%
|
$1,835,800
$67.37 P/Share
|
|
Nov 30
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
199,216
-0.64%
|
$13,347,472
$67.32 P/Share
|
|
Nov 27
2020
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
78,640
-0.33%
|
$5,347,520
$68.07 P/Share
|
|
Nov 18
2020
|
Presidio Management Group X LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,000
-32.85%
|
$1,320,000
$66.38 P/Share
|
|
Nov 17
2020
|
Jonathan D Root Director |
BUY
Other acquisition or disposition
|
Direct |
81,996
+50.0%
|
-
|
|
Nov 17
2020
|
Jonathan D Root Director |
SELL
Other acquisition or disposition
|
Indirect |
2,905,296
-53.33%
|
-
|
|
Nov 17
2020
|
Jonathan D Root Director |
BUY
Other acquisition or disposition
|
Indirect |
587,851
+50.0%
|
-
|
|
Nov 17
2020
|
Presidio Management Group X LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
890,851
+50.0%
|
-
|
|
Nov 17
2020
|
Presidio Management Group X LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
2,905,296
-53.33%
|
-
|
|
Nov 17
2020
|
Versant Ventures Iv, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
3,188,165
-68.41%
|
-
|
|
Nov 17
2020
|
Versant Ventures Iv, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
164,825
+50.0%
|
-
|
|
Nov 17
2020
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Direct |
8,837
+50.0%
|
-
|
|
Nov 17
2020
|
Kirk G. Nielsen Director |
SELL
Other acquisition or disposition
|
Indirect |
3,188,165
-68.41%
|
-
|
|
Nov 17
2020
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Indirect |
164,825
+50.0%
|
-
|